Clinical Trial Detail

NCT ID NCT04435691
Title Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Azacitidine + Hu5F9-G4 + Venetoclax

Age Groups: adult senior

No variant requirements are available.